Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Landon L Chan

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Journal of Hepatology|August 27, 2025
New targets and new drugs for hepatobiliary cancersStephen L Chan, Angela Lamarca, Chiun Hsu, et al.
Hepatology (Baltimore, Md.)|June 14, 2026
Beyond second-line therapy: Strategic sequencing of systemic treatments in advanced hepatocellular carcinomaMarta Fortuny, Landon L Chan, Leonardo G da Fonseca, et al.
Journal of Gastroenterology|December 10, 2013
Biochemical response to ursodeoxycholic acid predicts survival in a North American cohort of primary biliary cirrhosis patientsCraig Lammert, Brian D Juran, Erik Schlicht, et al.
Therapeutic Advances in Medical Oncology|December 9, 2024
Next-generation immunotherapy: igniting new hope for lung cancerMolly S C Li, Andrew L S Chan, Kevin K S Mok, et al.
Bioinformatics (Oxford, England)|January 13, 2018
A network approach to exploring the functional basis of gene-gene epistatic interactions in disease susceptibilityDanny Kit-Sang Yip, Landon L Chan, Iris K Pang, et al.
Journal of Hepatology|April 3, 2024
Multicentre phase II trial of cabozantinib in patients with hepatocellular carcinoma after immune checkpoint inhibitor treatmentStephen L Chan, Baek-Yeol Ryoo, Frankie Mo, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 15, 2024
Organ-specific responses to atezolizumab plus bevacizumab in advanced hepatocellular carcinoma: A multicentre, retrospective studyJaekyung Cheon, Sanghoon Jung, Jung Sun Kim, et al.
Investigational New Drugs|April 15, 2021
A phase II clinical study on the efficacy and predictive biomarker of pegylated recombinant arginase on hepatocellular carcinomaStephen L Chan, Paul N M Cheng, Angela M Liu, et al.
Journal of Hepatology|June 11, 2025
Attenuation of the second peak of bimodal recurrence of HBV-related HCC after curative treatment in the antiviral eraLandon L Chan, Anthony W H Chan, Terry C F Yip, et al.
Genome Biology|July 31, 2014
Whole-genome bisulfite sequencing of multiple individuals reveals complementary roles of promoter and gene body methylation in transcriptional regulationShaoke Lou, Heung-Man Lee, Hao Qin, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Journal of Hepatology|August 27, 2025
New targets and new drugs for hepatobiliary cancersStephen L Chan, Angela Lamarca, Chiun Hsu, et al.
Hepatology (Baltimore, Md.)|June 14, 2026
Beyond second-line therapy: Strategic sequencing of systemic treatments in advanced hepatocellular carcinomaMarta Fortuny, Landon L Chan, Leonardo G da Fonseca, et al.
Journal of Gastroenterology|December 10, 2013
Biochemical response to ursodeoxycholic acid predicts survival in a North American cohort of primary biliary cirrhosis patientsCraig Lammert, Brian D Juran, Erik Schlicht, et al.
Therapeutic Advances in Medical Oncology|December 9, 2024
Next-generation immunotherapy: igniting new hope for lung cancerMolly S C Li, Andrew L S Chan, Kevin K S Mok, et al.
Bioinformatics (Oxford, England)|January 13, 2018
A network approach to exploring the functional basis of gene-gene epistatic interactions in disease susceptibilityDanny Kit-Sang Yip, Landon L Chan, Iris K Pang, et al.
Journal of Hepatology|April 3, 2024
Multicentre phase II trial of cabozantinib in patients with hepatocellular carcinoma after immune checkpoint inhibitor treatmentStephen L Chan, Baek-Yeol Ryoo, Frankie Mo, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 15, 2024
Organ-specific responses to atezolizumab plus bevacizumab in advanced hepatocellular carcinoma: A multicentre, retrospective studyJaekyung Cheon, Sanghoon Jung, Jung Sun Kim, et al.
Investigational New Drugs|April 15, 2021
A phase II clinical study on the efficacy and predictive biomarker of pegylated recombinant arginase on hepatocellular carcinomaStephen L Chan, Paul N M Cheng, Angela M Liu, et al.
Journal of Hepatology|June 11, 2025
Attenuation of the second peak of bimodal recurrence of HBV-related HCC after curative treatment in the antiviral eraLandon L Chan, Anthony W H Chan, Terry C F Yip, et al.
Genome Biology|July 31, 2014
Whole-genome bisulfite sequencing of multiple individuals reveals complementary roles of promoter and gene body methylation in transcriptional regulationShaoke Lou, Heung-Man Lee, Hao Qin, et al.
Pageof 3